Literature DB >> 28343836

Cervical Cancer: Prevention and Early Detection.

Theresa A Kessler.   

Abstract

OBJECTIVE: To review effective methods of prevention that can be used to control the incidence of cervical cancer and detection strategies that can identify the precancerous lesions before they become true cancer. DATA SOURCES: Current medical, scientific and nursing literature, and national and international guidelines of cervical cancer.
CONCLUSION: Nearly all cervical cancers are caused by specific types of human papillomavirus (HPV). Prophylactic vaccination for HPV provides the most effective method of primary prevention against HPV-related diseases. The use of the Pap test and HPV test, according to published guidelines, provides the most effective means of screening for cervical cancer. IMPLICATIONS FOR NURSING PRACTICE: Nurses are in a key position to provide health education with the goal of supporting vaccine uptake and screening guidelines.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HPV vaccination; cervical cancer; cervical cancer screening; early detection; education

Mesh:

Year:  2017        PMID: 28343836     DOI: 10.1016/j.soncn.2017.02.005

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  50 in total

1.  Prevalence and correlates of cervical abnormalities among female sex workers in Tijuana, Mexico.

Authors:  Claire C Bristow; Brandon Brown; Logan Marg; Raquel I Iñiguez; Kristen Meckel-Parker; Jay G Silverman; Carlos Magis-Rodriguez; Tommi L Gaines; Kimberly C Brouwer
Journal:  Int J STD AIDS       Date:  2019-06-03       Impact factor: 1.359

Review 2.  Cancer Screening Considerations and Cancer Screening Uptake for Lesbian, Gay, Bisexual, and Transgender Persons.

Authors:  Marc Ceres; Gwendolyn P Quinn; Matthew Loscalzo; David Rice
Journal:  Semin Oncol Nurs       Date:  2018-01-08       Impact factor: 2.315

Review 3.  Research Progress in the Relationship Between P2X7R and Cervical Cancer.

Authors:  Yiqing Tang; Cuicui Qiao; Qianqian Li; Xiaodi Zhu; Ronglan Zhao; Xiaoxiang Peng
Journal:  Reprod Sci       Date:  2022-07-07       Impact factor: 3.060

4.  Application of vincristine and cisplatin combined with intensity-modulated radiation therapy in the treatment of patients with advanced cervical cancer.

Authors:  Heling Zhang; Ye Zhang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

5.  Cervical Cancer Screening and Associated Barriers among Women in India: A Generalized Structural Equation Modeling Approach.

Authors:  Nilima Nilima; Kalaivani Mani; Siddharth Kaushik; Shesh Nath Rai
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

6.  Bioinformatics Analysis Highlights Five Differentially Expressed Genes as Prognostic Biomarkers of Cervical Cancer and Novel Option for Anticancer Treatment.

Authors:  Hongtu Cui; Ruilin Ma; Tao Hu; Gary Guishan Xiao; Chengjun Wu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-17       Impact factor: 6.073

7.  Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer.

Authors:  Guang-Hui Du; Jun-Kang Wang; Jackson R Richards; Jia-Jia Wang
Journal:  Int Immunopharmacol       Date:  2018-11-16       Impact factor: 4.932

8.  POLG Gene Variants in Cervical Cancer Patients and Their Associations with Clinical and Pathomorphological Tumor Characteristics.

Authors:  Ieva Golubickaite; Rasa Ugenskiene; Egle Ziliene; Jurgita Beniusyte; Arturas Inciura; Lina Poskiene; Elona Juozaityte
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

9.  Hsa_circRNA_000543 Predicts Poor Prognosis and Promotes Cervical Cancer Cell Progression Through Regulating miR-567/ZNF268 Axis.

Authors:  Zhilan Yao; Liuping Shu; Yi Yi; Lifu Qiao
Journal:  Cancer Manag Res       Date:  2021-06-30       Impact factor: 3.989

10.  hsa_circ_0101119 facilitates the progression of cervical cancer via an interaction with EIF4A3 to inhibit TCEAL6 expression.

Authors:  Xuezuo Sui; Yanchun Wang; Hui Liu
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.